Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(2):250-258. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0015

View: 11332 Download: 198 Web of Science: 40 Crossref: 40

Review

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 18345 Download: 612 Web of Science: 40 Crossref: 37

Liver Imaging

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 11560 Download: 231 Web of Science: 11 Crossref: 13

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 11220 Download: 196 Web of Science: 79 Crossref: 69

Review

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 19791 Download: 544 Web of Science: 219 Crossref: 203

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 8156 Download: 194 Web of Science: 27 Crossref: 25

Imaging findings of mimickers of hepatocellular carcinoma

Tae Kyoung Kim, Eunchae Lee, Hyun-Jung Jang

Clin Mol Hepatol. 2015;21(4):326-343. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.326

View: 41617 Download: 977 Web of Science: 22 Crossref: 24

Original Article

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Jung Gil Park

Clin Mol Hepatol. 2015;21(3):287-294. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.287

View: 8433 Download: 73 Web of Science: 26 Crossref: 28

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 12917 Download: 146 Web of Science: 59 Crossref: 58

Influence of P53 on the radiotherapy response of hepatocellular carcinoma

Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão

Clin Mol Hepatol. 2015;21(3):257-267. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.257

View: 11213 Download: 117 Web of Science: 30 Crossref: 26

Editorial

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma

Yu Rim Lee, Soo Young Park

Clin Mol Hepatol. 2015;21(3):230-231. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.230

View: 6350 Download: 68 Web of Science: 12 Crossref: 10

Review

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 14034 Download: 381 Web of Science: 90 Crossref: 80

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9544 Download: 125 Web of Science: 24 Crossref: 26

Liver Pathology

Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation

Wonkyung Jung, Baek-hui Kim

Clin Mol Hepatol. 2015;21(2):183-186. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.183

View: 6649 Download: 62 Web of Science: 5 Crossref: 5

Original Article

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim

Clin Mol Hepatol. 2015;21(2):165-174. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.165

View: 9050 Download: 93 Web of Science: 17 Crossref: 16

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma

Kil Hyo Park, Soon Ha Kwon, Yong Sub Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim

Clin Mol Hepatol. 2015;21(2):158-164. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.158

View: 7846 Download: 116 Web of Science: 8 Crossref: 6

Review

New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(2):115-121. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.115

View: 10234 Download: 143 Web of Science: 40 Crossref: 31

Hepatitis C virus-induced hepatocellular carcinoma

Nicolas Goossens, Yujin Hoshida

Clin Mol Hepatol. 2015;21(2):105-114. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.105

View: 18528 Download: 336 Web of Science: 113 Crossref: 108

Liver Imaging

Recent advances in the imaging of hepatocellular carcinoma

Myung-Won You, So Yeon Kim, Kyoung Won Kim, So Jung Lee, Yong Moon Shin, Jin Hee Kim, Moon-Gyu Lee

Clin Mol Hepatol. 2015;21(1):95-103. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.95

View: 10265 Download: 119 Web of Science: 7 Crossref: 7

Case Report

Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Jin Ok Kim, Dae Won Jun, Hye Jin Tae, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon, Joon Soo Hahm

Clin Mol Hepatol. 2015;21(1):85-88. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.85

View: 8339 Download: 109 Web of Science: 12 Crossref: 11

Original Article

Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 7319 Download: 103 Web of Science: 2 Crossref: 3

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 8398 Download: 128 Web of Science: 21 Crossref: 21

Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells

Ha Ra Gu, Su Cheol Park, Su Jin Choi, Jae Cheol Lee, You Cheoul Kim, Chul Ju Han, Jin Kim, Ki Young Yang, Yeon Joo Kim, Geum Youb Noh, So Hyeon No, Jae-Hoon Jeong

Clin Mol Hepatol. 2015;21(1):49-59. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.49

View: 11781 Download: 121 Web of Science: 29 Crossref: 28

Liver Pathology

Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation

Kyoung-Bun Lee

Clin Mol Hepatol. 2014;20(3):313-316. Published online September 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.313

View: 6684 Download: 71 Web of Science: 12 Crossref: 14

Case Report

A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation

Yoon Serk Lee, Jeong Han Kim, Hyeon Young Yoon, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2014;20(3):306-309. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.306

View: 6159 Download: 48 Web of Science: 6 Crossref: 5

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with ⁹⁰Y microspheres

Sun Young Yim, Jin Dong Kim, Jin Yong Jung, Chang Ha Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Ho Sang Ryu, Yun Hwan Kim, Chong Suk Kim, Eun Shin

Clin Mol Hepatol. 2014;20(3):300-305. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.300

View: 7903 Download: 58 Web of Science: 8 Crossref: 10

Review

Prediction of fibrosis progression in chronic viral hepatitis

Grace Lai-Hung Wong

Clin Mol Hepatol. 2014;20(3):228-236. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.228

View: 13182 Download: 98 Web of Science: 37 Crossref: 36

Risk stratification of HBV infection in Asia-Pacific region

Jia-Horng Kao

Clin Mol Hepatol. 2014;20(3):223-227. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.223

View: 8799 Download: 85 Web of Science: 19 Crossref: 17

Liver Imaging

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall

Clin Mol Hepatol. 2014;20(2):218-222. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.218

View: 6459 Download: 78 Web of Science: 11 Crossref: 12

Original Article

Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US

Ji Hye Min, Hyo Keun Lim, Sanghyeok Lim, Tae Wook Kang, Kyoung Doo Song, Seo-youn Choi, Hyunchul Rhim, Min Woo Lee

Clin Mol Hepatol. 2014;20(1):61-70. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.61

View: 8697 Download: 110 Web of Science: 49 Crossref: 47

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 5597	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4811	MAFLD: How is it different from NAFLD?
Viewed By 4555	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3720	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3709	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search